Stay updated on Alirocumab on Postprandial Hyperlipemia in Type 2 Diabetes Clinical Trial

Sign up to get notified when there's something new on the Alirocumab on Postprandial Hyperlipemia in Type 2 Diabetes Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Alirocumab on Postprandial Hyperlipemia in Type 2 Diabetes Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The site revision label changed from v3.7.2 to v3.8.0.
    Difference
    0.1%
    Check dated 2026-10-28T15:28:32.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    A banner announces an NIH terminology transition, saying federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” and linking to updates and FAQs.
    Difference
    0.8%
    Check dated 2026-10-21T21:38:56.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The site footer now identifies the software as revision v3.7.2 instead of v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-14T21:41:16.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov software revision label changed from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-07T21:52:06.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The record history now shows the page revision as v3.7.0, replacing the previous v3.6.6.
    Difference
    0.1%
    Check dated 2026-09-16T22:20:19.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    The record history now shows a new revision tag v3.6.6. The previous revision v3.6.5 is removed, signaling an update to the page's revision metadata rather than content changes.
    Difference
    0.1%
    Check dated 2026-09-02T19:32:58.000Z thumbnail image

Stay in the know with updates to Alirocumab on Postprandial Hyperlipemia in Type 2 Diabetes Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Alirocumab on Postprandial Hyperlipemia in Type 2 Diabetes Clinical Trial page.